| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUGGACCGCUGUGCGCGAACCCUGAACCCUACGGUCCCGACCCGCGGG… | 1598 nt | 0.6946 | |
| AGUGGACCGCUGUGCGCGAACCCUGAACCCUACGGUCCCGACCCGCGGG… | 1770 nt | 0.6966 | |
| CGACUGCCGAGCUCCGCCCUCCAGGCGGCCCCACCCGCCUGCCGUCCUG… | 1718 nt | 0.6927 | |
| CGACUGCCGAGCUCCGCCCUCCAGGCGGCCCCACCCGCCUGCCGUCCUG… | 1682 nt | 0.6992 | |
| AGUGGACCGCUGUGCGCGAACCCUGAACCCUACGGUCCCGACCCGCGGG… | 1586 nt | 0.6942 |
This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
A study in rats demonstrated that the TYMP mRNA was up-regulated in whole brains in a blast intensity- and time-dependent manner following blast wave exposure, correlating with histological evidence of vascular injury and thrombosis [Balaban et al. DOI:10.1016/j.jneumeth.2016.02.001]. A study in mice demonstrated that the TYMP mRNA was significantly increased in magnetically isolated CD31+ endothelial cells from juvenile injured cortices compared to adult injured cortices following controlled cortical impact [Brickler et al. DOI:10.1523/JNEUROSCI.0914-18.2018].